Immune Tolerance Induction (ITI) is defined as a process by which the immune system is trained to better accept treatment with the missing clotting factor without producing further antibodies (inhibitors), and has now evolved as the standard of care with a potential to eradicate persistent FVIII or FIX inhibitors in Hemophilia. To elaborate more on this issue, Takeda and Docplexus have organized a webinar on 12th May 2020, Tuesday, 04:00 pm. Join the expert, Dr Savita Rangarajan who will be discussing her insights on Immune tolerance Induction: Learnings & way forward.
VV-MTG-3432 Disclaimer “The information contained herein is available to public for information purposes only; it should not be used for diagnosing or treating a health problem or disease. It is not intended to substitute for consultation with a healthcare provider. Please consult your healthcare provider for further…
